Mon, Dec 22, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Lyxor research finds reduced tail risk and a bumpy landing lie ahead for financial markets

Thursday, October 25, 2012

Beverly Chandler, Opalesque London: A research flash report from Lyxor Cross Asset Research Study for the fourth quarter of 2012, entitled 'Central Banks Buy More Time’ finds that hedge fund managers will benefit from stock selection.

The firm writes: "We believe the ECB’s "whatever it takes" promise substantially reduced tail risks. Risk premiums that have remained abnormally high since the outset of the financial crisis, should diminish over time." However, the firm warns that the road to normalization will probably be long and bumpy. "While policy uncertainties persist in the Eurozone, they are mounting in the U.S. which is facing the so-called "fiscal cliff". But the aggressive monetary policies across the world mean that the trough in the economic cycle could occur earlier than we previously had in mind".

Strategically, Lyxor continues to favor U.S. assets but have tactically raised their stance on the more volatile Eurozone equities to the same slight overweight stance. "Fundamentally, austerity continues to take its toll on European growth, thus compromising fiscal targets. Within Emerging markets, we believe EM equities should soon benefit from additional policy support and later from improved economic momentum" the firm writes.

For Lyxor, the most striking feature of financial markets since the crisis is probably investors’ inordinate antipathy towards equity. "Current equity risk premiums are far above......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. Opalesque Exclusive: U.S. legal receivables fund launched in August[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: Investing in asset-backed receivables is a strategy that has been an integral part of the alternative investment space within the overall fixed income asset c

  5. Comment - High fees and low performance hit hedge funds[more]

    From FT.com: Disenchantment over high fees and lackluster performance may finally be turning the tide against hedge funds, fresh data suggest. Despite generally weak returns since the global financial crisis, hedge funds have enjoyed positive net inflows every year since 2010. This helped assets und